Trek Financial, LLC Amgen Inc Transaction History

Trek Financial, LLC

$1.24 Billion
Q3 2024

A detailed history of Trek Financial, LLC transactions in Amgen Inc stock. As of the latest transaction made, Trek Financial, LLC holds 2,857 shares of AMGN stock, worth $740,820. This represents 0.07% of its overall portfolio holdings.

Number of Shares

2,857

Previous 1,330 114.81%

Holding current value

$740,820

Previous $415,000 121.69%

% of portfolio

0.07%

Previous 0.03%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $472,423 - $515,179	1,527 Added 114.81%	2,857 $920,000
Q2 2024 Aug 12, 2024	BUY	$262.75 - $319.31 $1,313 - $1,596	5 Added 0.38%	1,330 $415,000
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $1,075 - $1,298	4 Added 0.3%	1,325 $376,000
Q4 2023 Feb 08, 2024	SELL	$255.7 - $288.46 $151,374 - $170,768	-592 Reduced 30.95%	1,321 $380,000
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $3,717 - $4,614	-17 Reduced 0.88%	1,913 $514,000
Q2 2023 Aug 11, 2023	BUY	$214.27 - $253.37 $102,849 - $121,617	480 Added 33.1%	1,930 $428,000
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $21,450 - $26,144	95 Added 7.01%	1,450 $350,000
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $23,819 - $30,265	104 Added 8.31%	1,355 $355,000
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $1,571 - $1,772	7 Added 0.56%	1,251 $282,000
Q2 2022 Aug 10, 2022	BUY	$230.71 - $256.74 $11,074 - $12,323	48 Added 4.01%	1,244 $303,000
Q1 2022 May 10, 2022	SELL	$219.27 - $242.57 $21,269 - $23,529	-97 Reduced 7.5%	1,196 $289,000
Q4 2021 Jan 19, 2022	SELL	$198.88 - $227.6 $47,532 - $54,396	-239 Reduced 15.6%	1,293 $291,000
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $57,312 - $67,149	-270 Reduced 14.98%	1,532 $326,000
Q2 2021 Aug 06, 2021	BUY	$233.58 - $259.14 $28,963 - $32,133	124 Added 7.39%	1,802 $439,000
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $52,148 - $60,771	235 Added 16.29%	1,678 $418,000
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $3,245 - $3,865	15 Added 1.05%	1,443 $332,000
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $49,056 - $60,199	248 Added 21.02%	1,428 $337,000
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $25,878 - $34,321	-142 Reduced 10.74%	1,180 $239,000
Q4 2019 Feb 19, 2020	SELL	$189.21 - $243.2 $40,112 - $51,558	-212 Reduced 13.82%	1,322 $319,000
Q3 2019 Nov 08, 2019	SELL	$174.11 - $208.62 $204,579 - $245,128	-1,175 Reduced 43.37%	1,534 $297,000
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $144,195 - $169,029	865 Added 46.91%	2,709 $499,000
Q1 2019 May 14, 2019	BUY	$180.87 - $203.88 $121,182 - $136,599	670 Added 57.07%	1,844 $350,000
Q4 2018 Mar 14, 2019	BUY	$178.4 - $208.25 $209,441 - $244,485	1,174 New	1,174 $229,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $139B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trek Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trek Financial, LLC with notifications on news.

Account

Trek Financial, LLC Amgen Inc Transaction History